📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease. (2014)

First Author: Karran E

Attributed to: A systematic investigation into the pathogenesis and course of Parkinson's syndrome funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/ana.24188

PubMed Identifier: 24853080

Publication URI: http://europepmc.org/abstract/MED/24853080

Type: Journal Article/Review

Volume: 76

Parent Publication: Annals of neurology

Issue: 2

ISSN: 0364-5134